Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000031.xml
Klin Monbl Augenheilkd 2014; 231(11): 1127-1142
DOI: 10.1055/s-0033-1358022
DOI: 10.1055/s-0033-1358022
Augenheilkunde up2date
Neubildungen der Lider und chirurgische Rekonstruktionen
Periocular Tumours and Surgical ReconstructionFurther Information
Publication History
Publication Date:
24 November 2014 (online)
Die plastisch-rekonstruktive Lidchirurgie bietet eine Vielzahl an Operationsmethoden in einem anatomisch begrenzten Gebiet. Eine Auswahl der häufigsten Indikationen und der gängigsten Methoden werden in diesem Artikel vorgestellt. Ziel aller Lidrekonstruktionen ist eine möglichst vollwertige Wiederherstellung der normalen Lidfunktion bei einem ästhetisch optimalen Ergebnis für den Patienten [28]. Dabei muss besondere Rücksicht auf die einzelnen feinen Strukturen in dieser Region genommen werden, sodass die Integrität und Funktion der Lider postoperativ gewährleistet ist.
* gemeinsame Erstautorenschaft
-
Literatur
- 1 Ajaiyeoba AI. Malignant melanoma of the eyelid in the black – case report. West African J Med 1993; 12: 177-179
- 2 Allali J, DʼHermies F, Renard G. Basal cell carcinomas of the eyelids. Ophthalmologica 2005; 219: 57-71
- 3 Bakos RM, Kriz M, Mühlstädt M et al. Risk factors for early-onset basal cell carcinoma in a German institution. Eur J Dermatol 2011; 21: 705-709
- 4 Balch CM, Buzaid AC, Soong SJ et al. Final version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol 2001; 19: 3635-3648
- 5 Bechert CJ, Schnadig V, Nawgiri R. The Merkel cell carcinoma challenge. A review from the fine needle aspiration service. Cancer (Cancer Cytopathol) 2013; 121: 179-188
- 6 Bertelmann E, Rieck P, Hartmann C. Rekonstruktion von Hautdefekten in der Lid- und Periorbitalregion mittels vier Dreiecksverschiebelappen. Ophthalmologe 2006; 103: 120-123
- 7 Blake PW, Bradford PT, Devesa SS et al. Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study. Arch Dermatol 2010; 146: 625-632
- 8 Brash DE. Sunlight and the onset of skin cancer. Trends Genet 1997; 13: 410-414
- 9 Briggs EJ, Bartley G. Treatment options and future prospects for the management of eyelid malignancies. An evidence-based update. Ophthalmology 2001; 108: 2088-2098
- 10 Christenson LJ, Borrowman TA, Vachon CM et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005; 294: 681-690
- 11 Clark WH, From L, Bernardino EA et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705-726
- 12 Collin JRO. A Manual of systematic Eyelid Surgery. Philadelphia: Elsevier Health Sciences; 2006
- 13 Connelly TJ, Cribier B, Brown TJ et al. Complete spontaneous regression of Merkel cell carcinoma: A review of the 10 reported cases. Dermatol Surg 2000; 26: 853-856
- 14 Cook BE, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology 1999; 106: 746-750
- 15 Cook BE, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies. Ophthalmology 2001; 108: 2088-2098
- 16 Cutler NL, Beard C. A new method for partial and total upper lid reconstruction. Am J Ophthalmol 1955; 39: 1-7
- 17 Dailey JR, Kennedy RH, Flaharty PM et al. Squamous cell carcinoma of the eyelid. Ophthal Plast Reconstr Surg 1994; 10: 153-159
- 18 Dhawan SS, Wolf DJ, Rabinovitz HS et al. Lentigo maligna. Arch Dermatol 1990; 126: 928-930
- 19 Donaldson MJ, Sullivan TJ, Whitehead KJ et al. Squamous cell carcinoma of the eyelids. Br J Ophthalmol 2002; 86: 1161-1165
- 20 Dores GM, Curtis RE, Toro JR et al. Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms. Cancer 2008; 113: 3372-3381
- 21 Doxanas MT, Iliff WJ, Iliff NT et al. Squamous cell carcinoma of the eyelids. Ophthalmology 1987; 94: 538-541
- 22 Esmaeli B, Wang B, Deavers M et al. Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthal Plast Reconstr Surg 2000; 16: 250-257
- 23 Esmaeli B. Sentinel node biopsy as a tool for accurate staging of eyelid and conjunctival malignancies. Curr Opin Ophthalmol 2002; 13: 317-323
- 24 Fitzpatrick TB, Wolff K. Fitzpatrickʼs Dermatology in general Medicine. New York: McGraw-Hill Medical; 2008
- 25 Foote M, Harvey J, Porceddu S et al. Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin. Int J Radiat Oncol Biol Phys 2010; 77: 677-684
- 26 Gonnermann J, Klein JP, Klamann MK et al. Dry eye symptoms in patients after eyelid reconstruction with full-thickness eyelid defects: using the Tomey TG-1000 thermographer. Ophthalmic Res 2012; 48: 192-198
- 27 Hill DC, Gramp AA. Surgical treatment of lentigo maligna and lentigo maligna melanoma. Australasian J Dermatol 1999; 40: 25-30
- 28 Hintschich C. Periocular plastic surgery. Dtsch Arztebl Int 2010; 107: 141-146
- 29 Holbach L, Cursiefen C, Jünemann A et al. Differenzialdiagnose bei Lidtumoren. Teil I. Ophthalmologe 2002; 99: 394-413
- 30 Hughes WL. A new method for rebuilding a lower lid. Report of a case. Arch Ophthalmol 1937; 17: 1008-1017
- 31 Hughes WL. Reconstruction of the lids. Am J Ophthalmol 1945; 28: 1203-1211
- 32 Hübner H. Lidrekonstruktion: funktionelle und ästhetische Aspekte. Klin Monatsbl Augenheilkd 2014; 231: 17-27
- 33 Jelfs PL, Giles G, Shugg D et al. Cutaneous malignant melanoma in Australia, 1989. Med J Austr 1994; 161: 182-187
- 34 Klein-Theyer A, Horwath-Winter J, Dieter FR et al. Evaluation of ocular surface and tear film function following modified Hughes tarsoconjunctival flap procedure. Acta Ophthalmol 2014; 92: 286-290
- 35 Kruse R, Ruzicka T. DNA mismatch repair and the significance of a sebaceous skin tumor for visceral cancer prevention. Trends Mol Med 2004; 10: 136-141
- 36 Leibovitch I, Huilgol SC, Selva D et al. Basal cell carcinoma treated with Mohs surgery in Australia II: outcome at 5 year follow-up. J Am Acad Dermatol 2005; 53: 452-457
- 37 Lo Muzio L, Nocini PF, Savoia A et al. Nevoid basal cell carcinoma syndrome. Clinical findings in 37 Italian affected individuals. Clin Genet 1999; 55: 34-40
- 38 Mai C, Bertelmann E. Oral mucosal grafts: old technique in new light. Ophthalmic Res 2013; 50: 91-98
- 39 Malhotra R, Chen C, Huilgol SC et al. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmology 2003; 110: 2011-2018
- 40 Margo CE, Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol 1993; 38: 169-192
- 41 Mustardé JC. Repair and Reconstruction in the orbital Region. 3rd. ed. Edinburgh: Churchill Livingstone; 1991
- 42 Paavilainen V, Tuominen J, Pukkala E et al. Basal cell carcinoma of the eyelid in Finland during 1953-97. Acta Ophthalmol Scand 2005; 83: 215-220
- 43 Rodriguez-Sains RS. Melanoma of the eyelid. Plast Reconstr Surg 1999; 103: 2080-2081
- 44 Roewert-Huber J, Lange-Aschenfeldt B, Stockfleth E et al. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 2007; 157: 47-51
- 45 Sekulic A, Migden MR, Oro AE et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012; 366: 2171-2179
- 46 Sharkawi E, Hamedani M, Fouladi M. Eyelid squamous cell carcinoma in situ treated with topical 5-fluorouracil. Clin Exp Ophthalmol 2011; 39: 915-916
- 47 Shields CL, Naseripour M, Shields JA et al. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma. Ophthalmology 2002; 109: 2129-2133
- 48 Shields JA, Shields CL. Atlas of Eyelid & conjunctival Tumors. Philadelphia: Lippincott Williams & Wilkins; 1999
- 49 Stang A, Stabenow R, Eisenger B et al. Site- and gender-specific time trend analyses of the incidence of skin melanomas in the former German Democratic Republic (GDR) including 19351 cases. Eur J Cancer 2003; 39: 1610-1618
- 50 Stannard CE, Sealy GRH, Hering ER. Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine-125 brachytherapy. Ophthalmology 2000; 107: 951-958
- 51 Swaika A, Crozier JA, Joseph RW. Vemurafenib: an evidence-based review of its clinical utility in the treatment of metastatic melanoma. Drug Des Devel Ther 2014; 8: 775-787
- 52 Tenzel RR. Reconstruction of the central half of an eyelid. Arch Ophthalmol 1975; 93: 125-126
- 53 Thosani MK, Schneck G, Jones EC. Periocular squamous cell carcinoma. Dermatol Surg 2008; 34: 585-599
- 54 Tsao H, Atkins MB, Sober AJ. Management of cutaneous melanoma. N Engl J Med 2004; 351: 998-1012
- 55 Vaziri M, Buffam FV, Matrinka M et al. Clinicopathologic features and behavior of cutaneous eyelid melanoma. Ophthalmology 2002; 109: 901-908
- 56 Verity DH, Collin JR. Eyelid reconstruction: the state of the art. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 344-348
- 57 von Hoff DD, LoRusso PM, Rudin CM et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009; 361: 1164-1172
- 58 Wali UK, Al-Mujaini A. Sebaceous gland carcinoma of the eyelid. Oman J Ophthalmol 2010; 3: 117-121
- 59 Wang CJ, Zhang HN, Wu H et al. Clinicopathologic features and prognostic factors of malignant eyelid tumors. Int J Ophthalmol 2013; 6: 442-447
- 60 Weedon D. Neuroendocrine carcinomas.Weedonʼs skin pathology. 3rd. ed. London: Churchill Livingstone Elsevier; 2010